Advanced glycation end products and schizophrenia: A systematic review
Youssef Kouidrat(Assistance Publique – Hôpitaux de Paris), Masanari Itokawa(Fujita Health University), Makoto Arai(Tokyo Metropolitan Institute of Medical Science), Mitsuhiro Miyashita(Tokyo Metropolitan Institute of Medical Science), Ali Amad(King's College London), Gwenolé Loas(Erasmus Hospital), Jean‐Daniel Lalau(Inserm)
Cited by 51
Related Papers
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Structure of pathological TDP-43 filaments from ALS with FTLD
|Nature|2021|326
Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights
|Cell Reports|2018|264
Brain Cannabinoid CB2 Receptor in Schizophrenia
|Biological Psychiatry|2009|184
Enhanced Carbonyl Stress in a Subpopulation of Schizophrenia
|Archives of General Psychiatry|2010|166